The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. Until today this year the stock’s price performance recorded a decrease of -38.54%. However, over the last six months, the performance has been stronger by -34.26%. The price of RXRX decreased -2.00% over the last 30 days. And in the last five days, it has fallen by -27.36%.
The stock market performance of Recursion Pharmaceuticals Inc has been fairly unsteady. Over the last year, the company’s stock hit its highest at $12.36 on 02/18/25, while the lowest price during the same time frame was $3.79, recorded on 04/09/25.
52-week price history of RXRX Stock
The history of a stock’s 52-week high and low prices can provide important information about its current state and future potential. Recursion Pharmaceuticals Inc’s current trading price is -66.38% away from its 52-week high, while its distance from the 52-week low is 9.63%. The stock’s price range for this period has been between $3.79 and $12.36. The Healthcare sector company’s shares saw a trading volume of about 31.36 million for the day, which was higher than the average daily volume of 25.29 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
Recursion Pharmaceuticals Inc (RXRX) has experienced a quarterly decline of -45.40% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.67B.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 6.72, with a change in price of -4.11. Similarly, Recursion Pharmaceuticals Inc recorded 22,099,229 in trading volume during the last 100 days, posting a change of -49.70%.
RXRX’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for RXRX stands at 0.10. Similarly, the long-term debt-to-equity ratio is also 0.08.
RXRX Stock Stochastic Average
As of today, the raw stochastic average of Recursion Pharmaceuticals Inc over the last 50 days is at 7.52%. This shows a declinee from the raw stochastic average of the previous 20 days, which was recorded at 15.95%. Further, the company’s Stochastic %K and %D values for the last 20 days were 46.62% and 63.46%, respectively.
